Regulatory circuitry governing fungal development, drug resistance, and disease.
Open accessThe DOI matches its Crossref record; 662 of the 662 references it cites were found in a registry or an index.
Abstract
SUMMARY: Pathogenic fungi have become a leading cause of human mortality due to the increasing frequency of fungal infections in immunocompromised populations and the limited armamentarium of clinically useful antifungal drugs. Candida albicans , Cryptococcus neoformans , and Aspergillus fumigatus are the leading causes of opportunistic fungal infections. In these diverse pathogenic fungi, complex signal transduction cascades are critical for sensing environmental changes and mediating appropriate cellular responses. For C. albicans , several environmental cues regulate a morphogenetic switch from yeast to filamentous growth, a reversible transition important for virulence. Many of the signaling cascades regulating morphogenesis are also required for cells to adapt and survive the cellular stresses imposed by antifungal drugs. Many of these signaling networks are conserved in C. neoformans and A. fumigatus , which undergo distinct morphogenetic programs during specific phases of their life cycles. Furthermore, the key mechanisms of fungal drug resistance, including alterations of the drug target, overexpression of drug efflux transporters, and alteration of cellular stress responses, are conserved between these species. This review focuses on the circuitry regulating fungal morphogenesis and drug resistance and the impact of these pathways on virulence. Although the three human-pathogenic fungi highlighted in this review are those most frequently encountered in the clinic, they represent a minute fraction of fungal diversity. Exploration of the conservation and divergence of core signal transduction pathways across C. albicans , C. neoformans , and A. fumigatus provides a foundation for the study of a broader diversity of pathogenic fungi and a platform for the development of new therapeutic strategies for fungal disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The 1,3-β-D-glucan synthases are encoded by FKS1, FKS2, and FKS3 in S. cerevisiae, C. glabrata, and C. albicans, and require a regulatory subunit encoded by RHO1 for activity [3], [20], [32], [33].”
From Global Analysis of the Evolution and Mechanism of Echinocandin Resistance in Candida glabrata (2012) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mechanisms of acquired resistance mostly fall into two classes (Figure 1B): (i) mutations leading to increased expression of the target or the alteration of its binding affinity towards the drug; and (ii) mutations leading to reduced intracellular accumulation of the drug by means of increasing the activity or expression of drug efflux pumps or, conversely, reducing the import of the drug [69].”
From Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens (2018) · cites this paper as [69]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Finally, resistant strains with no known resistance-conferring mutations in target genes have also been reported [6,69], implying the presence of yet undiscovered mechanisms.”
From Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens (2018) · cites this paper as [69]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Inhibition by azoles commonly leads to depletion of ergosterol and accumulation of other sterols, such as lanosterol, eburicol and the toxic 14α-methyl-3,6-diol, within fungal cell membranes (Watson et al., 1989; Shapiro et al., 2011; Chen et al., 2016).”
From Abnormal Ergosterol Biosynthesis Activates Transcriptional Responses to Antifungal Azoles (2018) · cites this paper as Shapiro et al., 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Most of antifungal drugs in the clinic targeting the biosynthesis of ergosterol inhibit the activities of ERG enzymes and direct the biosynthesis of the ergosterol pathway to an alternative route”
From The synthesis, regulation, and functions of sterols in Candida albicans: Well-known but still lots to learn (2016) · cites this paper as [40]
Experimental — accuracy not yet measured
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 601–662 of 662
Jiang, H., Ouyang, H., Zhou, H., & Jin, C. (2008) · Microbiology · doi:10.1099/mic.0.2008/019240-0 · Cited by 43
Jung, K.-W., Kim, S.-Y., Okagaki, L. H., Nielsen, K., & Bahn, Y.-S. (2011) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2010.10.006 · Cited by 42
Do, J. H., Yamaguchi, R., & Miyano, S. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-306 · Cited by 42 · cited 1×
“The heat shock response of this fungus has been the subject of in-depth investigations (2, 154, 418).”
BackgroundJuvvadi, P. R., Fortwendel, J. R., Pinchai, N., Perfect, B. Z., Heitman, J., & Steinbach, W. J. (2008) · Eukaryotic Cell · doi:10.1128/ec.00200-08 · Cited by 42 · cited 2×
“The deletion of cnaA or the inhibition of calcineurin pharmacologically causes abnormal septation and a loss of conidiophore formation (261), which may explain the morphogenetic defect.”
BackgroundWarn, P. A., Sharp, J., Morrissey, G., & Denning, D. W. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.09.029 · Cited by 41
Guerrero, A., Jain, N., Wang, X., & Fries, B. C. (2010) · Infection and Immunity · doi:10.1128/iai.01049-09 · Cited by 41
Antifungal Therapy of Murine Aspergillus terreus Infection
Graybill, J. R., Hernandez, S., Bocanegra, R., & Najvar, L. K. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3715-3719.2004 · Cited by 41
Metabolic control of antifungal drug resistance
Robbins, N., Collins, C., Morhayim, J., & Cowen, L. E. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.07.004 · Cited by 40 · cited 2×
“Recently, a study has shown that rapamycin decreases erg3-mediated azole resistance (489).”
BackgroundSelf-citationAspergillus fumigatus Calcipressin CbpA Is Involved in Hyphal Growth and Calcium Homeostasis
Pinchai, N., Perfect, B. Z., Juvvadi, P. R., Fortwendel, J. R., Cramer, R. A., Asfaw, Y. G., Heitman, J., Perfect, J. R., & Steinbach, W. J. (2009) · Eukaryotic Cell · doi:10.1128/ec.00336-08 · Cited by 40
The effects of antifungal agents to conidial and hyphal forms of Aspergillus fumigatus
van de Sande, W. W. J., Tavakol, M., van Vianen, W., & Bakker‐Woudenberg, I. A. J. M. (2009) · Medical Mycology · doi:10.3109/13693780802713497 · Cited by 40
Dermoumi, H. (1994) · Chemotherapy · doi:10.1159/000239178 · Cited by 39
Orsi, C. F., Colombari, B., Ardizzoni, A., Peppoloni, S., Neglia, R., Posteraro, B., Morace, G., Fadda, G., & Blasi, E. (2009) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2008.00470.x · Cited by 39
The RGS Protein Crg2 Regulates Pheromone and Cyclic AMP Signaling in Cryptococcus neoformans
Shen, G., Wang, Y.-L., Whittington, A., Li, L., & Wang, P. (2008) · Eukaryotic Cell · doi:10.1128/ec.00154-08 · Cited by 39
Deletion of the NOT4 gene impairs hyphal development and pathogenicity in Candida albicans
Krueger, K. E., Ghosh, A. K., Krom, B. P., & Cihlar, R. L. (2004) · Microbiology · doi:10.1099/mic.0.26792-0 · Cited by 38
Lionakis, M. S., Lewis, R. E., Chamilos, G., & Kontoyiannis, D. P. (2005) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.2005.25.9.1174 · Cited by 38
Menon, V., Li, D., Chauhan, N., Rajnarayanan, R., Dubrovska, A., West, A. H., & Calderone, R. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05438.x · Cited by 38
Mitchell, B. M., Wu, T. G., Jackson, B. E., & Wilhelmus, K. R. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-0793 · Cited by 37
Boisnard, S., Ruprich‐Robert, G., Florent, M., Silva, B. D., Chapeland‐Leclerc, F., & Papon, N. (2008) · Yeast · doi:10.1002/yea.1636 · Cited by 36
Predicting the emergence of resistance to antifungal drugs
Cowen, L. (2001) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(01)00362-7 · Cited by 36
Self-citationHope, H., Schmauch, C., Arkowitz, R. A., & Bassilana, M. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2010.07186.x · Cited by 35
Qiao, J., Liu, W., & Li, R. (2010) · Mycopathologia · doi:10.1007/s11046-010-9309-2 · Cited by 34
Xu, Z. Q., Zhang, L., Zhang, J., Cao, Y., Yu, Y.-Y., Wang, D., Ying, K., Chen, W., & Jiang, Y. (2006) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2006.03.004 · Cited by 33
Pseudohyphal Regulation by the Transcription Factor Rfg1p in Candida albicans
Cleary, I. A., Mulabagal, P., Reinhard, S. M., Yadev, N. P., Murdoch, C., Thornhill, M. H., Lazzell, A. L., Monteagudo, C. C., Thomas, D. P., & Saville, S. P. (2010) · Eukaryotic Cell · doi:10.1128/ec.00088-10 · Cited by 33
Mss11, a Transcriptional Activator, Is Required for Hyphal Development in Candida albicans
Su, C., Li, Y., Lü, Y., & Chen, J. (2009) · Eukaryotic Cell · doi:10.1128/ec.00190-09 · Cited by 33
Umeyama, T., Kaneko, A., Niimi, M., & Uehara, Y. (2006) · Yeast · doi:10.1002/yea.1373 · Cited by 31 · cited 2×
“Hgc1 provides a fascinating link between morphogenesis and virulence, as the hgc1 mutant is defective in yeastto-hypha morphogenesis but still expresses hypha-specific genes implicated in virulence, including HWP1 and ECE1 (652).”
BackgroundAntifungal Resistance Mechanisms of Aspergillus
Qiao, J., Liu, W. Y., & Li, R. (2008) · Nippon Ishinkin Gakkai Zasshi · doi:10.3314/jjmm.49.157 · Cited by 31
1,4-Oligoglucosides Inhibit the Binding of Aspergillus fumigatus Conidia to Human Monocytes
Kan, V. L., & Bennett, J. E. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/163.5.1154 · Cited by 31
Afcwh41is required for cell wall synthesis, conidiation, and polarity inAspergillus fumigatus
Zhang, L., Zhou, H., Ouyang, H., Li, Y., & Jin, C. (2008) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2008.01376.x · Cited by 31
Russell, C. L., & Brown, A. J. P. (2005) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2005.04.008 · Cited by 30
Yuan, X., Mitchell, B. M., Hua, X., Davis, D. A., & Wilhelmus, K. R. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-4726 · Cited by 30
Stewart, E., Hawser, S., & Gow, N. A. R. (1989) · Archives of Microbiology · doi:10.1007/bf00414430 · Cited by 30
Du, W., Coaker, M., Sobel, J. D., & Akins, R. A. (2004) · Current Genetics · doi:10.1007/s00294-004-0499-3 · Cited by 29
Infection-Associated Genes of Candida Albicans
Hube, B. (2006) · Future Microbiology · doi:10.2217/17460913.1.2.209 · Cited by 29
Eschertzhuber, S., Velik‐Salchner, C., Hoermann, C., Hoefer, D., & Lass‐Flörl, C. (2007) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2007.00252.x · Cited by 28
Deletion of the msdS/AfmsdC gene induces abnormal polarity and septation in Aspergillus fumigatus
Li, Y., Zhang, L., Wang, D., Zhou, H., Ouyang, H., Ming, J., & Jin, C. (2008) · Microbiology · doi:10.1099/mic.0.2008/017525-0 · Cited by 28
Human albumin promotes germination, hyphal growth and antifungal resistance by Aspergillus fumigatus
Rodrigues, A. G., Araujo, R., & Pina-Vaz, C. (2005) · Medical Mycology · doi:10.1080/13693780500129814 · Cited by 28
Dissection of the Candida albicans class I chitin synthase promoters
Lenardon, M. D., Lesiak, I., Munro, C. A., & Gow, N. A. R. (2009) · Molecular Genetics and Genomics · doi:10.1007/s00438-009-0423-0 · Cited by 27
Lettner, T., Zeidler, U., Gimona, M., Hauser, M., Breitenbach, M., & Bito, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011993 · Cited by 26
Fang, W., Ding, W., Wang, B., Zhou, H., Ouyang, H., Ming, J., & Jin, C. (2010) · Glycobiology · doi:10.1093/glycob/cwp206 · Cited by 26
Hoot, S. J., Brown, R. P., Oliver, B. G., & White, T. C. (2010) · Eukaryotic Cell · doi:10.1128/ec.00130-10 · Cited by 25
Blankenship, J. R., Singh, N., Alexander, B. D., & Heitman, J. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.1.464-467.2005 · Cited by 25
Fine structure and physiology of conidial germination in Aspergillus fumigatus
Campbell, C. (1971) · Transactions of the British Mycological Society · doi:10.1016/s0007-1536(71)80054-2 · Cited by 25
Fungal Molecular Pathogenesis: What Can It Do and Why Do We Need It?
Perfect, J. R., & Casadevall, A. (2014) · ASM Press eBooks · doi:10.1128/9781555815776.ch1 · Cited by 24
Oliver, B. G., Panepinto, J. C., Fortwendel, J. R., Smith, D. L., Askew, D. S., & Rhodes, J. C. (2002) · Mycopathologia · doi:10.1023/a:1015533406565 · Cited by 24
Morris, M., & Smith, S. H. (1996) · The Lancet · doi:10.1016/s0140-6736(05)65945-4 · Cited by 24
Transcript profiling of a MAP kinase pathway in C. albicans
Huang, H., Harcus, D., & Whiteway, M. S. (2008) · Microbiological Research · doi:10.1016/j.micres.2008.03.001 · Cited by 23
Depletion of the Cullin Cdc53p Induces Morphogenetic Changes in Candida albicans
Trunk, K., Gendron, P., Nantel, A., Lemieux, S., Roemer, T., & Raymond, M. (2009) · Eukaryotic Cell · doi:10.1128/ec.00332-08 · Cited by 23
Polyene Sensitivity during Germination of Conidia of Aspergillus fumigatus
Russell, N. J., Kerridge, D., & Gale, E. F. (1975) · Journal of General Microbiology · doi:10.1099/00221287-87-2-351 · Cited by 22
Dabas, N., Schneider, S., & Morschhäuser, J. (2008) · Eukaryotic Cell · doi:10.1128/ec.00229-08 · Cited by 22
Fuller, K. K., Zhao, W., Askew, D. S., & Rhodes, J. C. (2009) · Eukaryotic Cell · doi:10.1128/ec.00391-08 · Cited by 21
Aller, A. I., Claro, R. M., Castro, C., Serrano, C., Colom, M. F., & Martín‐Mazuelos, E. (2007) · Chemotherapy · doi:10.1159/000102585 · Cited by 20
Torosantucci, A., Angiolella, L., Filesi, C., & Cassone, A. (1984) · Microbiology · doi:10.1099/00221287-130-12-3285 · Cited by 19
Bhabhra, R., Richie, D. L., Kim, H. S., Nierman, W. C., Fortwendel, J. R., Aris, J. P., Rhodes, J. C., & Askew, D. S. (2008) · Eukaryotic Cell · doi:10.1128/ec.00412-07 · Cited by 19
Organization of antibiotic amphotericin B in model lipid membranes
Gruszecki, W. I., Gagoś, M., Hereć, M., & Kernen, P. (2002) · Cellular & Molecular Biology Letters · Cited by 18
Wilson, D., Fiori, A., Brucker, K. D., Dijck, P. V., & Stateva, L. I. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2010.06.006 · Cited by 18
A Candida albicans homolog of CDC25 is functional in Saccharomyces cerevisiae
GOLDBERG, D., Marbach, I., Gross, E., Levitzki, A., & Simchen, G. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17748.x · Cited by 16
Su, Z., Li, H., Li, Y., & Ni, F. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.10.008 · Cited by 16
Gene Regulation during Morphogenesis in Candida albicans
Brown, A. J. P., Barelle, C. J., Budge, S., Duncan, J., Harris, S. J., Lee, P. R., Leng, R. P., Macaskill, S., Murad, A. M. A., Ramsdale, M., et al. (2000) · KARGER eBooks · doi:10.1159/000060347 · Cited by 16
Mos10 (Vps60) is required for normal filament maturation in Saccharomyces cerevisiae
Köhler, J. R. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03556.x · Cited by 15
Blasi, E., Pitzurra, L., Chimienti, A. R., Mazzolla, R., Puliti, M., Barluzzi, R., & Bistoni, F. (1995) · Infection and Immunity · doi:10.1128/iai.63.4.1253-1257.1995 · Cited by 12
Fusarium sporodochia on cutaneous wounds.
Smith, M. B., & Mcginnis, M. (2005) · Medical Mycology · doi:10.1080/13693780410001712089 · Cited by 11
Whittington, A., & Wang, P. (2010) · Medical Mycology · doi:10.3109/13693786.2010.512618 · Cited by 4
Research works printed but not linked: 6
- Clinical Laboratory Standards Institute 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts, 3rd ed. Approved standard M27-A3. Clinical and Laboratory Standards Institute, Wayne, PA.
- 10.1111/j.1574-6968.2001.tb10853.x · doi:10.1111/j.1574-6968.2001.tb10853.x · Paper page
- 10.1128/am.25.2.309-312.1973 · doi:10.1128/am.25.2.309-312.1973 · Paper page
- 10.1091/mbc.e03-11-0782 · DOI · Paper page
- Kwon-ChungK. J. BennettJ. E.. 1992. Medical Mycology. Lea & Febiger, Philadelphia, PA.
- PrasadT.. 2010. Morphogenic regulator EFG1 affects the drug susceptibilities of pathogenic Candida albicans. FEMS Yeast Res. 10:587–596.
Cited by
Growth of Candida albicans hyphae
Sudbery, P. E. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2636 · Cited by 1,110
Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond
Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00199 · Cited by 801
Self-citationMechanisms of Antifungal Drug Resistance
Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D., & Perlin, D. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019752 · Cited by 647
“Elevated chitin content following echinocandin exposure is also observed in C. tropicalis, C. parapsilosis, and Candida guillermondii, in addition Cell wall stress Target alteration or overexpression Up-regulation of multidrug transporters Cellular stress responses - Mediators of stress-response pathways include: Hsp9…”
BackgroundInfluentialSelf-citationAntifungal Drug Development: Challenges, Unmet Clinical Needs, and New Approaches
Roemer, T., & Krysan, D. J. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019703 · Cited by 593
“fumigatus, and that it is observed in an invertebrate model of candidiasis (Cowen et al. 2009; Singh et al. 2009; Shapiro et al. 2011).”
BackgroundCandida albicans cell-type switching and functional plasticity in the mammalian host
Noble, S. M., Gianetti, B. A., & Witchley, J. N. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.157 · Cited by 521
Metadata
- Authors
- Shapiro, R. S., Robbins, N., & Cowen, L. E.
- Affiliations
- University of Toronto (CA)
- Venue
- Microbiology and Molecular Biology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2011-06
- Volume
- 75
- Issue
- 2
- Pages
- 213-267
- ISSN
- 1092-2172 (ISSN-L)
- 1098-5557
- PMC
- PMC3122626
- OpenAlex
- W2114409750
- Cited by
- 576
- References
- 662
- Citations by year
- 2026: 21 · 2025: 35 · 2024: 34 · 2023: 33 · 2022: 33 · 2021: 44 · 2020: 51 · 2019: 51 · 2018: 46 · 2017: 51 · 2016: 27 · 2015: 43 · 2014: 35 · 2013: 34 · 2012: 32
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Microbiology and Molecular Biology Reviews (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research (MOP-86452)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- fungal pathogens, signal transduction, fungal morphogenesis, drug resistance, Candida albicans, Cryptococcus neoformans, Aspergillus fumigatus, yeast-to-hypha transition, drug target alterations, cellular stress response, fungal virulence, opportunistic fungal infection, conserved signaling pathways
- MeSH terms
- Antifungal Agents, Fungi, Humans, Mycoses, Signal Transduction, Drug Resistance, Fungal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.